Results 131 to 140 of about 31,914 (284)

Health Benefits of Polysaccharides in Red Algae: A Comprehensive Review

Food Frontiers, Volume 7, Issue 2, March 2026.
Graphical abstract showing the health benefits of red algal polysaccharides. ABSTRACT Humans have long consumed red algae (especially by the Asian community), and their polysaccharide extracts (carrageenan, agar) are extensively used in the food industry as gel thickeners.
Sammueal Jun Kai Ong, Matthew Myint, Sean Chia, Chee Fan Tan, Yi Fan Hong, Meiyappan Lakshmanan, Ying Swan Ho, Thomas T. Wheeler, Xuezhi Bi, Ian Walsh, Kuin Tian Pang   +10 more
wiley   +1 more source

Secondary ischemic stroke prevention in patients with atrial fibrillation: results of the ROCKET AF study

Медицинский совет, 2014
The article tells about prevention of ischemic stroke (IS) in patients after IS or transient ischemic attack (TIA) against a background of non-valvular atrial fibrillation (AF).
V. A. Parfyonov, S. V. Verbitskaya
doaj   +1 more source

Use of direct oral anticoagulants in patients with atrial fibrillation in Scotland : applying a coherent framework to drug utilisation studies [PDF]

, 2017
Purpose: To report the use of direct oral anticoagulants (DOAC) for stroke prevention in patients with atrial fibrillation (AF) in Scotland and advocate the standardisation of drug utilisation research methods.
Alvarez-Madrazo, Samantha, Bennie, Marion, Mueller, Tanja, Robertson, Charles   +3 more
core   +1 more source

Suboptimal use of non-vitamin K antagonist oral anticoagulants

Medicine, 2016
This study aimed to investigate the potential misuse of novel oral anticoagulants (NOACs) and the physicians' adherence to current European guideline recommendations in real-world using a large dataset from Real-life Multicenter Survey Evaluating Stroke Prevention Strategies in Turkey (RAMSES Study).RAMSES study is a prospective, multicenter ...
Basaran, Ozcan, Dogan, Volkan, Beton, Osman, Tekinalp, Mehmet, Aykan, Ahmet Cagri, Kalaycioglu, Ezgi, Bolat, Ismail, Tasar, Onur, Safak, Ozgen, Kalcik, Macit, Yaman, Mehmet, Inci, Sinan, Altintas, Bernas, Kalkan, Sedat, Kirma, Cevat, Biteker, Murat, Karadeniz, Fatma Ozpamuk, Tekkesin, Ahmet Ilker, Cakilli, Yasin, Turkkan, Ceyhan, Hamidi, Mehmet, Demir, Vahit, Gursoy, Mustafa Ozan, Ozturk, Mujgan Tek, Aksan, Gokhan, Seyis, Sabri, Balli, Mehmet, Alici, Mehmet Hayri, Bozyel, Serdar, Altun, Ibrahim, Calik, Feyza, Karaca, Oguz, Helvaci, Fusun, Akay, Kadriye, Canga, Yigit, Celebi, Savas, Altuntas, Emine, Ayturk, Mehmet, Gunes, Haci Murat, Bezgin, Tahir, Aksakal, Aytekin, Cakal, Beytullah, Colak, Ayse, Kaplan, Ozgur, Tatlisu, Adem, Gozubuyuk, Gokhan, Demirelli, Selami, Kaya, Adnan, Rencuzogullari, Ibrahim, Bayram, Zubeyde, Simsek, Zeki, Civan, Murat, Batgharel, Ulaankhu, Ata, Ali Ekber, Gol, Gokhan, Mert, Gurbet Ozge, Mert, Kadir Ugur, Degirmencioglu, Aleks, Candan, Ozkan, Celebi, Ozlem Ozcan, Dogan, Cem, Yavuz, Fethi, Ulucan, Seref, Arisoy, Arif, Sahin, Bingul Dilekci, Ermis, Emrah, Gokaslan, Serkan, Pektas, Idris, Tanindi, Asli, Tekin, Kamuran, Sancar, Kadriye Memic, Cekic, Edip Guvenc, Basaran, Nesrin Filiz   +72 more
openaire   +7 more sources

Bioactive Phytochemical Compounds in Medicago sativa L. (Alfalfa): A Systematic Review of Biological Properties and Therapeutic Relevance in Nutraceutical and Functional Food Implications

Food Frontiers, Volume 7, Issue 2, March 2026.
ABSTRACT Medicago sativa L. (alfalfa) harbors a remarkably diverse reservoir of bioactive secondary metabolites. Flavonoids, isoflavones, and triterpenoid saponins dominate its bioactivity landscape, driving potent antioxidant, anti‐inflammatory, antimicrobial, estrogenic, hypolipidemic, and cytotoxic actions through redox modulation, membrane ...
Parham Joolaei Ahranjani, Hamid Rashidi Nodeh, Zahra Esfandiari, Giovanna Ferrentino   +3 more
wiley   +1 more source

Use of sodium‐glucose cotransporter‐2 inhibitors among older adults with type 2 diabetes mellitus in British Columbia

Diabetes, Obesity and Metabolism, Volume 28, Issue 3, Page 1915-1923, March 2026.
Abstract Aims Clinical guidelines recommend sodium‐glucose cotransporter‐2 inhibitors (SGLT2is) for individuals with type 2 diabetes mellitus (T2DM) and established or high risk of cardiorenal disease. This study examined real‐world SGLT2i use patterns among older adults with T2DM in British Columbia, Canada.
Hanin Harbi, Gregory Carney, Colin Dormuth, Jacob Volmer Stidsen, Iliana Lega, Lisa M. McCarthy, Guillaume Grenet, Anshula Ambasta, Raha Eskandari, Anton Pottegård, Wade Thompson   +10 more
wiley   +1 more source

Diagnostic and therapeutic approach in adult patients with traumatic brain injury receiving oral anticoagulant therapy: an Austrian interdisciplinary consensus statement

Critical Care, 2019
There is a high degree of uncertainty regarding optimum care of patients with potential or known intake of oral anticoagulants and traumatic brain injury (TBI).
Marion Wiegele, Herbert Schöchl, Alexander Haushofer, Martin Ortler, Johannes Leitgeb, Oskar Kwasny, Ronny Beer, Cihan Ay, Eva Schaden   +8 more
doaj   +1 more source

Strategies to Improve the Lipophilicity of Hydrophilic Macromolecular Drugs

Advanced Healthcare Materials, Volume 15, Issue 5, 2 February 2026.
Hydrophilic macromolecular drugs can be successfully lipidized by covalent attachment of lipids, by hydrophobic ion pairing with negatively or positively charged surfactants, and by dry or wet reverse micelle formation. Lipophilicity enhancement of hydrophilic macromolecules has several benefits including stability and bioavailability improvement ...
Sera Lindner, Stefan Keim, Soheil Haddadzadegan, Odile Fernandez Romero, Katrin Zöller, Gabriel Stern, Ilaria Cesi, Krum Kafedjiiski, Andreas Bernkop‐Schnürch   +8 more
wiley   +1 more source

Improved Stroke Prevention in Atrial Fibrillation After the Introduction of Non–Vitamin K Antagonist Oral Anticoagulants: The Stockholm Experience

Stroke, 2018
Background and Purpose— The purpose of this study was to investigate the impact of improved antithrombotic treatment in atrial fibrillation after the introduction of non–vitamin K antagonist oral anticoagulants on the incidence of stroke and bleeding in ...
T. Forslund, J. Komen, M. Andersen, B. Wettermark, M. von Euler, A. Mantel‐Teeuwisse, F. Braunschweig, P. Hjemdahl   +7 more
semanticscholar   +1 more source

CYP2C19 genotype testing for clopidogrel: A guideline developed by the UK Centre of Excellence in Regulatory Science and Innovation in Pharmacogenomics (CERSI‐PGx)

British Journal of Clinical Pharmacology, Volume 92, Issue 2, Page 329-347, February 2026.
Clopidogrel, an antiplatelet agent, is currently licensed in the United Kingdom for the prevention and treatment of atherothrombotic events in cerebrovascular disease, coronary artery disease and peripheral arterial disease. Clopidogrel requires metabolic activation by the cytochrome P450 enzyme CYP2C19 to be effective.
Cinzia Dello Russo, Iain Frater, Rebecca Kuruvilla, Stefanie Lip, Hannah O'Neill, Kerry Burke, Vicky Chaplin, Alexander S. F. Doney, Salim Elyas, Nicholas Greaves, Sophie Harding, David Hargroves, Judith Hayward, Dyfrig A. Hughes, Tom A. T. Hughes, Sree Kondapally, Patrick Mok, Aaron Peace, Imran Rafi, Simon Ray, Vicky Stinton, Luigi Venetucci, Munir Pirmohamed   +22 more
wiley   +1 more source